col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


31 Results       Page 1

 [1] 
Informa UK (Taylor & Francis): Statistics in Biopharmaceutical Research
  original article Date Title Authors   All Authors
1 [GO] 2023―May―10 Vaccine development during a pandemic: General lessons for clinical trial design Benjamin Hofner, Elina Asikanius, Wolfgang Jacquet, Theodor Framke, Katrien Oude Rengerink, Lukas Aguirre Dávila, et al. (+8)
2 [GO] 2023―Feb―07 Rejoinder: Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions Kelly Van Lancker, Sergey Tarima, Jonathan Bartlett, Madeline Bauer, Bharani Bharani-Dharan, Frank Bretz, et al. (+5)
3 [GO] 2023―Feb―07 Comment on “Estimands and Their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions” Mouna Akacha, Tianmeng Lyu
4 [GO] 2023―Feb―07 Comment on” Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions” Stijn Vansteelandt
5 [GO] 2022―Jul―25 Cancer Clinical Trials Beyond Pandemic: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion Rajeshwari Sridhara, Elizabeth Barksdale, Olga Marchenko, Qi Jiang, Yuki Ando, Erick Bloomquist, et al. (+26)
6 [GO] 2022―Jul―05 Leveraging Real-World Data in COVID-19 Response Freda Cooner, Ran Liao, Junjing Lin, Sophie Barthel, Yodit Seifu, Shiling Ruan
7 [GO] 2022―Jun―27 Estimands and their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions Kelly Van Lancker, Sergey Tarima, Jonathan Bartlett, Madeline Bauer, Bharani Bharani-Dharan, Frank Bretz, et al. (+5)
8 [GO] 2021―Nov―08 Statistical Issues and Challenges in Clinical Trials for COVID-19 Treatments, Vaccines, Medical Devices and Diagnostics Freda Cooner, Toshimitsu Hamasaki, Frank Bretz, Gene Pennello, Martin Posch
9 [GO] 2021―Nov―05 Predicting the COVID-19 Pandemic Impact on Clinical Trial Recruitment Nicky Best, Inna Perevozskaya, Dave Lunn, Graeme Archer, Jack Euesden, Christina Fillmore, et al. (+3)
10 [GO] 2021―Jun―11 Quantifying efficiency gains of innovative designs of two-arm vaccine trials for COVID-19 using an epidemic simulation model Rob Johnson, Chris Jackson, Anne Presanis, Sofia S. Villar, Daniela De Angelis
11 [GO] 2021―Apr―22 Statistical Observations on Vaccine Clinical Development for Pandemic Diseases Scott Patterson, Bo Fu, Ya Meng, Fabrice Bailleux, Josh Chen
12 [GO] 2021―Apr―19 Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials Tomorrow Gianna McMillan, Cristiana Mayer, Rui Tang, Yi Liu, Lisa LaVange, Zoran Antonijevic, Robert A. Beckman
13 [GO] 2021―Mar―18 A Phase 3 trial analysis proposal for mitigating the impact of the COVID-19 pandemic Eva Hua, Reinhold Janocha, Thomas Severin, Jiawei Wei, Marc Vandemeulebroecke
14 [GO] 2021―Jan―29 Discrete Time Multi-State Model with Regime Switching for Modelling COVID-19 Disease Progression and Clinical Outcomes Sujatro Chakladar, Ran Liao, Will Landau, Margaret Gamalo, Yanping Wang
15 [GO] 2020―Dec―17 Statistical Opportunities to Accelerate Development for COVID-19 Therapeutics Fanni Natanegara, Névine Zariffa, Joan Buenconsejo, Ran Liao, Freda Cooner, Divya Lakshminarayanan, et al. (+3)
16 [GO] 2020―Dec―14 Mitigating Study Power Loss Caused by Clinical Trial Disruptions Due to the COVID-19 Pandemic: Leveraging External Data via Propensity Score-Integrated Approaches Heng Li, Wei-Chen Chen, Nelson Lu, Changhong Song, Chenguang Wang, Ram Tiwari, et al. (+2)
17 [GO] 2020―Nov―05 The Role of FDA CDER Statisticians in Response Efforts to the COVID-19 Pandemic Sylva H. Collins, Dionne Price, Laura Lee Johnson
18 [GO] 2020―Oct―28 Statistical Challenges in the Conduct and Management of Ongoing Clinical Trials During the COVID-19 Pandemic Toshimitsu Hamasaki, Frank Bretz, Freda Cooner, Lisa M. LaVange, Martin Posch
19 [GO] 2020―Aug―20 Assessing via Simulation the Operating Characteristics of the WHO Scale for COVID-19 Endpoints Michael O’Kelly, Siying Li
20 [GO] 2020―Aug―05 Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19 Mary Nilsson, Brenda Crowe, Greg Anglin, Greg Ball, Melvin Munsaka, Seta Shahin, Wei Wang
21 [GO] 2020―Jul―23 Embedding a COVID-19 group sequential clinical trial within an ongoing trial: lessons from an unusual experience Pierre-François Dequin, Amélie Le Gouge, Elsa Tavernier, Bruno Giraudeau, Sarah Zohar
22 [GO] 2020―Jul―22 Clinical trials impacted by the COVID-19 pandemic: Adaptive designs to the rescue? Cornelia Ursula Kunz, Silke Jörgens, Frank Bretz, Nigel Stallard, Kelly Van Lancker, Dong Xi, et al. (+3)
23 [GO] 2020―Jul―20 Machine learning for clinical trials in the era of COVID-19 William R. Zame, Ioana Bica, Cong Shen, Alicia Curth, Hyun-Suk Lee, Stuart Bailey, et al. (+4)
24 [GO] 2020―Jul―20 Operational Experiences in China and Statistical Issues on the Conduct of Clinical Trials During the COVID-19 Pandemic Tong Guo, Chian Chen, Chieh Chiang, Chi-Tian Chen, Chin-Fu Hsiao
25 [GO] 2020―Jul―02 Efficient adaptive designs for clinical trials of interventions for COVID-19 Nigel Stallard, Lisa Hampson, Norbert Benda, Werner Brannath, Thomas Burnett, Tim Friede, et al. (+11)
26 [GO] 2020―Jul―01 The Impact of Major Events on Ongoing Non-inferiority Trials, With Application to COVID-19 Brian L. Wiens, Ilya Lipkovich
27 [GO] 2020―Jul―01 Challenges in assessing the impact of the COVID-19 pandemic on the integrity and interpretability of clinical trials Mouna Akacha, Janice Branson, Frank Bretz, Bharani Dharan, Paul Gallo, Insa Gathmann, et al. (+4)
28 [GO] 2020―Jun―25 Assessing the Impact of COVID-19 on the Objective and Analysis of Oncology Clinical Trials - Application of the Estimand Framework Evgeny Degtyarev, Kaspar Rufibach, Yue Shentu, Godwin Yung, Michelle Casey, Stefan Englert, et al. (+7)
29 [GO] 2020―Jun―25 Under a black cloud glimpsing a silver lining: Comment on Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic Rob Hemmings
30 [GO] 2020―Jun―08 Comment on: Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic Sylva H. Collins, Mark S. Levenson
31 [GO] 2020―Jun―08 Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic R. Daniel Meyer, Bohdana Ratitch, Marcel Wolbers, Olga Marchenko, Hui Quan, Daniel Li, et al. (+12)
 [1] 

31 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec